Literature DB >> 28283829

The efficacy of the direct clinical intervention for infectious diseases by a pediatric infectious disease specialist in the pediatric ward of a tertiary medical facility without a pediatric antimicrobial stewardship program.

T Hoshina1, N Yamamoto2, M Ogawa2, T Nakamoto2, K Kusuhara2.   

Abstract

Antimicrobial stewardship programs (ASPs) have been introduced in most hospital complexes; however, they are not always useful for pediatric patients. The aim of this study is to investigate the efficacy of direct clinical intervention for infectious diseases by a pediatric infectious disease specialist in a tertiary medical facility without pediatric ASP. This retrospective study included 1,821 patients who were hospitalized in the pediatric ward of a large metropolitan hospital from 2010 to 2015. The clinical course, the use of intravenous antimicrobial agents and the results of a microbiological analysis were compared between the period after the beginning of direct intervention by the specialist (post-intervention period) and the previous period (pre-intervention period). In the post-intervention period, the proportion of the patients who received intravenous antimicrobial agents, the number of antimicrobial agents used for each episode, and the proportion of episodes in which an antimicrobial agent was re-administrated were significantly lower (P = 0.006, P = 0.004, P = 0.036, respectively), and the duration of antimicrobial treatment was significantly shorter (P < 0.001). In addition, narrower spectrum antimicrobial agents were used, and the incidence of meropenem-sensitive Pseudomonas aeruginosa significantly increased (P = 0.037) in the post-intervention period. There was no change of mortality between the two periods. Direct clinical intervention by a pediatric infectious diseases specialist is useful for the treatment of infectious diseases in the pediatric ward of a tertiary medical facility without a pediatric ASP. The creation of a pediatric ASP is recommended in hospital complexes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28283829     DOI: 10.1007/s10096-017-2952-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

Review 2.  Antimicrobial stewardship for neonates and children: a global approach.

Authors:  Julia Bielicki; Rebecca Lundin; Sanjay Patel; Stéphane Paulus
Journal:  Pediatr Infect Dis J       Date:  2015-03       Impact factor: 2.129

3.  Benefits of a pediatric antimicrobial stewardship program at a children's hospital.

Authors:  M Cecilia Di Pentima; Shannon Chan; Jobayer Hossain
Journal:  Pediatrics       Date:  2011-11-21       Impact factor: 7.124

4.  The value of infectious diseases consultation in Staphylococcus aureus bacteremia.

Authors:  Hitoshi Honda; Melissa J Krauss; Jeffrey C Jones; Margaret A Olsen; David K Warren
Journal:  Am J Med       Date:  2010-05-20       Impact factor: 4.965

5.  Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals.

Authors:  Ron E Polk; Samuel F Hohmann; Sofia Medvedev; Omar Ibrahim
Journal:  Clin Infect Dis       Date:  2011-10-13       Impact factor: 9.079

6.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

7.  Antimicrobial stewardship programs in freestanding children's hospitals.

Authors:  Adam L Hersh; Stephen A De Lurgio; Cary Thurm; Brian R Lee; Scott J Weissman; Joshua D Courter; Thomas V Brogan; Samir S Shah; Matthew P Kronman; Jeffrey S Gerber; Jason G Newland
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

8.  Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.

Authors:  Jina Lee; Hyunjoo Pai; Yun Kyung Kim; Nam Hee Kim; Byung Wook Eun; Hyoung Jin Kang; Kyoung Ho Park; Eun Hwa Choi; Hee Young Shin; Eui Chong Kim; Hoan Jong Lee; Hyo Seop Ahn
Journal:  J Antimicrob Chemother       Date:  2007-06-27       Impact factor: 5.790

9.  Variation in paediatric hospital antibiotic guidelines in Europe.

Authors:  N Spyridis; G Syridou; H Goossens; A Versporten; J Kopsidas; G Kourlaba; J Bielicki; N Drapier; T Zaoutis; M Tsolia; M Sharland
Journal:  Arch Dis Child       Date:  2015-09-28       Impact factor: 3.791

10.  Reduction of Broad-Spectrum Antimicrobial Use in a Tertiary Children's Hospital Post Antimicrobial Stewardship Program Guideline Implementation.

Authors:  Kelley R Lee; Bindiya Bagga; Sandra R Arnold
Journal:  Pediatr Crit Care Med       Date:  2016-03       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.